National Alliance for Eye and Vision Research
Advocacy Center
Become an Advocate for Vision Research
Eye Fact Center
Press Center
Newsletters
Spread the Word
Tell Your Story
Link to Our Site
Resources and Links
Privacy Policy
Site Map
Press Center
About the Alliance National Eye Institute Contact Us
Become an Advocate for Vision Research - Join the Action List
Speak Up for Eye and Vision Research
Enter Your Zip Code   
 
FOR IMMEDIATE RELEASE
May 22, 2006
CONTACT: James F. Jorkasky
Executive Director
240-221-2905
jamesj@eyeresearch.org

NAEVR has formally requested that "Eye and Vision Research" be added to categories eligible for peer-reviewed funding within the Congressionally-directed Medical Research Program (CDMRP) within the Department of Defense (DOD). It was first added to the list of eligible categories last year as part of the FY2006 Defense Appropriations bill.

The CDMRP program is funded through the Military Quality of Life appropriations bill in the House, where it has already been added to this year's bill, thanks to the effort of Rep. Jim Walsh (R-NY). In the Senate it is funded through the DOD appropriations bill. NAEVR is working through Senator Kay Bailey Hutchison (R-TX) to include it in that chamber's bill. By including it in both the House and Senate's bills, it would be much more likely to be included in the final conference commmittee version.

To read NAEVR's FY2007 justification submitted to Congress requesting the inclusion of Eye and Vision Research in the CDMPR program, click here.

The National Alliance for Eye and Vision Research (NAEVR) is a non-profit advocacy coalition comprised of 55 professional, consumer and industry organizations involved in eye and vision research. NAEVR’s goal is to achieve the best vision for all Americans through advocacy and public education for eye and vision research sponsored by the National Institutes of Health (NIH), the National Eye Institute (NEI) and other federal research entities. Visit NAEVR’s Web site at www.eyeresearch.org to access NAEVR’s Senate testimony